The key biomarkers that were associated with atherosclerosis progression in MINOCA patients are sVCAM-1 and CCL-21, which may suggest a complex genesis of atherosclerosis progression due to the structurally altered plaques and changes in the microcirculatory bed. The gene discussed is CCL21; the disease is atherosclerosis.